National Association of Attorneys General
All 56 State and Territory Attorneys General Ask Congress to Permanently Classify Fentanyl-Related Substances as Schedule I Drugs
For Release: Dec. 11, 2019 | Noon ET
Contact: Ashley Wynstra | 202-326-6027 | email@example.com
Washington, D.C. --- The National Association of Attorneys General (NAAG) sent a letter to Senate leadership, urging Congress to permanently classify fentanyl-related substances as Schedule I drugs. Schedule I drugs are defined as drugs with no currently accepted medical use and a high potential for abuse.
All 56 state and territory attorneys general signed the letter asking Congress to pass S. 2701, the Federal Initiative to Guarantee Health by Targeting (FIGHT) Fentanyl Act.
The Drug Enforcement Administration (DEA) issued a temporary scheduling order in February 2018 to schedule fentanyl-related substances that has allowed federal law enforcement authorities to bring criminal actions against individuals who manufacture, distribute or handle fentanyl-related substances. This scheduling order is set to expire less than two months from now on Feb. 6, 2020. The FIGHT Fentanyl Act codifies DEA precedent to schedule fentanyl-related substances.
The FIGHT Fentanyl Act will ensure law enforcement agencies and courts retain the tools needed to keep those who traffic in this deadly substance off the streets.
In the most recent data available from the Centers for Disease Control and Prevention, there were 72,000 drug-related deaths in the United States in 2017. Of those deaths, roughly 40% involved fentanyl or a fentanyl-related compound.
Photos from the letter signing are available here.
# # #
The National Association of Attorneys General (NAAG) was founded in 1907 to help attorneys general fulfill the responsibilities of their office and to assist in the delivery of high-quality legal services to the states and territorial jurisdictions.